본문 바로가기
KERD
논문KCI 등재

金水六君煎이 이산화황으로 유발된 흰쥐의 호흡기 점액 및 뮤신생성에 미치는 영향

Effect of Geumsuyukgunjeon on Airway Mucus Secretion and Mucin Production

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives In this study, effect of Geumsuyukgunjeon (GYJ) on the increase in airway epithelial mucosubstances of rats with acute bronchitis and EGF-induced MUC5AC mucin production from human airway epithelial cells were investigated. Materials and Methods Hypersecretion of airway mucus was induced by exposure of rats to SO2 during 3 weeks. Effect of orally-administered GYJ during 2 weeks on increase in airway epithelial mucosubstances from tracheal goblet cells of rats was assesed using histopathological analysis after staining the epithelial tissue with PAS-alcian blue. Possible cytotoxicity of GYJ was assessed by examining the potential damage of kidney and liver functions by measuring serum GOT/GPT activities and serum BUN and creatinine concentrations of rats and the body weight gain during experiment, after administering GYJ orally. Effect of GYJ on EGF-induced MUC5AC mucin production from human airway epithelial cells (A549) was investigated. Confluent A549 cells were pretreated for 30 min in the presence of GYJ and treated with EGF (25 ng/ml) for 24 hrs, to assess the effect of GYJ on EGF-induced MUC5AC mucin production using enzyme-linked immunosorbent assay (ELISA). Results (1) GYJ decreased the amount of intraepithelial mucosubstances of trachea of rats. (2) GYJ did not show kidney and liver toxicities and did not affect body weight gain of rats during experiment. (3) GYJ significantly inhibited EGF-induced MUC5AC mucin production from A549 cells. Conclusions The result from the present study suggests that GYJ might control both the mucus hypersecretion in vivo and do not show in vivo toxicity to liver and kidney functions after oral administration and the production of pulmonary mucin.

Abstract

Objectives In this study, effect of Geumsuyukgunjeon (GYJ) on the increase in airway epithelial mucosubstances of rats with acute bronchitis and EGF-induced MUC5AC mucin production from human airway epithelial cells were investigated. Materials and Methods Hypersecretion of airway mucus was induced by exposure of rats to SO2 during 3 weeks. Effect of orally-administered GYJ during 2 weeks on increase in airway epithelial mucosubstances from tracheal goblet cells of rats was assesed using histopathological analysis after staining the epithelial tissue with PAS-alcian blue. Possible cytotoxicity of GYJ was assessed by examining the potential damage of kidney and liver functions by measuring serum GOT/GPT activities and serum BUN and creatinine concentrations of rats and the body weight gain during experiment, after administering GYJ orally. Effect of GYJ on EGF-induced MUC5AC mucin production from human airway epithelial cells (A549) was investigated. Confluent A549 cells were pretreated for 30 min in the presence of GYJ and treated with EGF (25 ng/ml) for 24 hrs, to assess the effect of GYJ on EGF-induced MUC5AC mucin production using enzyme-linked immunosorbent assay (ELISA). Results (1) GYJ decreased the amount of intraepithelial mucosubstances of trachea of rats. (2) GYJ did not show kidney and liver toxicities and did not affect body weight gain of rats during experiment. (3) GYJ significantly inhibited EGF-induced MUC5AC mucin production from A549 cells. Conclusions The result from the present study suggests that GYJ might control both the mucus hypersecretion in vivo and do not show in vivo toxicity to liver and kidney functions after oral administration and the production of pulmonary mucin.

참고문헌 (35)

  1. Kim KB, "Hanbangsoacheongsonyeonuihak", pp.339~340 (2010), Ui Sung Dang Publishing Co
  2. Ali M, "Analysis of the protome of human airway epithelial secretions", Proteome Sci, 9, pp.4~ (2011)
  3. Sim YS, "Clinical respiratiry system", pp.6~8 (1990), Iljogak
  4. Lee CJ, "Pathophysiologic characteristics of airway mucus-hypersecretory diseases and experimental models", Biomol Ther, 6(1), pp.1~8 (1998)
  5. Rogers DF, "Airway mucus hypersecretion in asthma : an undervalued pathpology", Curr Opin Pharmacol, 4(3), pp.241~250 (2004)
  6. Rogers DF, "Treatment of airway mucus hypersecretion", Annal Med, 38(2), pp.116~125 (2006)
  7. Hong WS, "Gukyeok kangeokzeonseo", pp.34~ (1992), Iljungsa
  8. Yan YM, "Kangeokzeonseo", pp.1920~ (2006), Hanmiuihak
  9. Lee HG, "Donguipyegeneagwahak", pp.114~ (2004), Gukjingihoek
  10. Lee SY, "Effects of Gyurnsuyukgunjun on the injured tracheal tissue induced SO2 in rats", Korean J Orient Med, 2(1), pp.226~235 (1996)
  11. Kam CW, "Experimental study of the effects of Gyumsuyukgunjun on the pulmonary injury caused by exposute of cigarette smoke in rat", Korea Institute of Sci Technol Inf, 3(1), pp.261~278 (1997)
  12. 김춘석, "金水六君煎이 ovalbumin으로 誘發된 mice의 喘息에 미치는 影響", 대한한의학회지, 23(3), pp.522~536 (2002), 대한한의학회
  13. Song JJ, "Effect of Kamkeumsooyukkunjeon on allergy and lung damage", Korean Soc Orient Med Pathol, 14(2), pp.70~79 (2002)
  14. Hwang DY, "Bangyakhappyeon", pp.148~149 (2002), Yonglimsa
  15. Pon DJ, "Hyperplastic effects of aerosolized sodium metasulfite on rat airway mucus-secretory epithelial cells", Can J Physiol Pharmacol, 72(9), pp.1025~1030 (1994)
  16. Lee, CJ, "Effects of poly-L-arginine on the mucin release from airway goblet cells of hamster and on the mucosubstances of airway goblet cells of rat", J Appl Pharmacol, 9(4), pp.263~269 (2001)
  17. St George JA, "An immunohistochemical characterization of Rhesus monkey respiratoty secretions using monoclonal antibodies", Am Rev Resp Dis, 132, pp.556~563 (1985)
  18. Shao MXG, "Tumor necrosis factor alpha converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells", Proc Natl Acad Sci USA, 100, pp.11618~11623 (2003)
  19. Song KS, "Interleukin-1β and tumor necrosis factor-alpha Induce MUC5AC overexpression through a mechanism involving ERK", p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells, 2003, pp.278, 23243~23250
  20. The Korean Acedemy of Pediatric Allergy and Respiratory Disease, "Pediatrics allergy immunology pulmonology", pp.267~ (2005), Goonjachulpansa
  21. Kang YI, "Silyongjongeigwahak", pp.455~461 (1995), Sanghaigwahakgisulchulpansa
  22. "Patients survey in 2013"[URL]
  23. "Survey of diseases and service: acute bronchitis(J20), chronic bronchitis(J242)"[URL]
  24. Jany B, "Mucin gene expression in rat airways following infectin and irritation", Biocherm Biophys Res Comm, pp.181~ (1991)
  25. The Korean Acedemy of Asthma, Allergy and clinical immunology, "Asthma and allergy", pp.73~76 (2002), Gunjachulpansa
  26. Culpiitt SV, "Sputum matrix metalloprotease : comparison between chronic obstructive pulmonary disease and asthma", Respir Med, 99(6), pp.703~710 (2005)
  27. Kim DJ, "Measurement of mucin amounts using RTO3 in patients with chronic airway disease", Tuberc Respir Dis, 47(6), pp.792~793 (1999)
  28. Zuhji Alimam M, "Muc-5", 5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways, 2000, pp.22, 253~260
  29. Hoorens PR, "Genome wide analysis of the bovine mucin genes and their gastrointestinal transcription profile", BMC Genomics, 12, pp.140~ (2011)
  30. Rousseau K, "Muc5b and muc5a are the major oligomeric mucins in equine airway mucus", Am J Physiol Lung Cell Mol Physiol, 292, pp.1396~1404 (2007)
  31. Shim JJ, "Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice", J Allergy Clin Immunol, 105, pp.739~745 (2000)
  32. Jung HJ, "Review of literatures about sputum on west-oriental medicine", J Orient Chronic Dis, 1(1), pp.51~62 (1995)
  33. Lee SI, "Hanyakilmsangyeongyong", pp.355~356 (1986), Sungbosa
  34. Sin MG, "Ilmsangyeongyongbonchuhak", pp.176~177 (1988), Namsandang
  35. Bea BC, "Ilmsangbangjahak", pp.414~ (1995), Sungbosa

관련 논문AI추천

이 간행물의 다른 논문 (5건)